Ben Franklin Technology Partners of Southeastern Pennsylvania

AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial and static-resistant properties, offering protection against bodily fluids while being reusable and recyclable. The company focuses on delivering high-quality, comfortable, and eco-friendly personal protective equipment that is entirely made and sourced in the USA. Additionally, AmorSui provides a platform for managing and procuring reusable kits, utilizing data analytics to monitor product life cycles, thereby helping hospitals and companies reduce costs and minimize waste while ensuring employee safety.

RecoveryLink is a developer of a digital recovery support platform aimed at improving behavioral health outcomes. The platform provides a comprehensive suite of services, including electronic recovery records, asynchronous digital training, individual telerecovery peer services, and live video group-based recovery support. By offering these tools, RecoveryLink seeks to enhance accessibility and effectiveness in recovery support, ultimately transforming systems within the behavioral health sector.

Pression is a developer of a patented, non-invasive smart compression platform known as the Wave, which aims to enhance circulation throughout the body and improve cardiac function. The primary focus of the company is to assist heart failure patients, addressing the issue of excess fluid retention, a leading cause of hospitalizations in the United States. By increasing oxygen delivery to vital organs, the Wave system seeks to enhance exercise tolerance and overall quality of life for individuals with circulatory conditions. The technology is built on established scientific principles and offers improvements over previous systems, emphasizing patient independence and health.

Repisodic is a health IT platform that makes it easy for patients and healthcare providers to find optimal post-acute care. Repisodic works with hospitals, patients, and post-acute care providers to revolutionize care decision-making. Our unique, patient-facing solution is used by case managers in the hospital room to present a customized list of discharge options to each patient and then guide the patient through the provider selection process.

OsciFlex LLC, founded in 2017 and based in Philadelphia, Pennsylvania, specializes in developing a wearable medical device aimed at preventing blood clots in patients. The device functions by stimulating calf muscle contractions through a muscle stretch reflex, which promotes valve sinus recirculatory flow. This innovative approach helps to prevent venous thromboembolism (VTE), a serious condition that can lead to significant health complications. By offering an alternative to traditional anti-coagulation pharmaceuticals, which can be costly and carry risks, OsciFlex aims to enhance patient care and reduce healthcare costs associated with blood clot management.

Mediscore Health is a physician-led company that specializes in providing data insights and technology-driven solutions for chronic care management and risk adjustment, primarily targeting Medicare Advantage payers and Accountable Care Organizations (ACOs). Founded in 2017 and headquartered in Philadelphia, with an additional location in Santa Monica, Mediscore offers a range of services, including physician-driven chart reviews, analytics, predictive diagnostics, and point-of-care disease management. The company's solutions are designed to assist healthcare providers in diagnosing, documenting, and managing patients with chronic illnesses at the primary care level, thereby enhancing patient care and optimizing healthcare outcomes.

ChromaTan Inc. specializes in developing continuous countercurrent tangential chromatography (CCTC) technology for the purification of monoclonal antibodies and proteins. The company's innovative platform addresses significant process bottlenecks in therapeutic protein production, offering a cost-effective, column-free, and continuous purification solution. This technology has undergone extensive beta testing with numerous leading biotech firms, demonstrating a 5-15 times increase in throughput while maintaining or improving product quality. Founded in 2007 and headquartered in Lower Gwynedd, Pennsylvania, ChromaTan aims to provide scalable and efficient alternatives to traditional large-scale column chromatography processes, thereby lowering production costs for biotechnology and contract manufacturing companies.

SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical company located in Jenkintown, Pennsylvania. The company specializes in creating drugs derived from microbiome-derived metabolites aimed at treating chronic inflammatory diseases and cancer. By harnessing compounds discovered in the human microbiome, SFA Therapeutics seeks to provide innovative therapeutic solutions for various medical conditions, including autoimmune diseases and liver disorders.

Open Medical Innovation is an organization founded by leaders from Archimedic, NextFab, and the University of Pennsylvania. We launched this organization with a focus on addressing the shortage of Personal Protective Equipment (PPE) during the COVID-19 outbreak. We intend to use this website to share information, collect feedback, and fulfill the unmet needs of patients and providers.

Cogwear is a brain technology company focused on addressing the needs of individuals suffering from anxiety and depression. The firm is developing a next-generation wearable device that enhances traditional physical measurements by integrating cognitive and emotional insights. This innovation aims to transition brain monitoring from laboratory settings to everyday life, providing users with real-time access to clinical-grade cognitive and emotional data. Utilizing AI-powered algorithms and proprietary dry electroencephalography (EEG) sensors, the wearable comfortably and accurately measures brain activity. The device captures and analyzes brainwaves, enabling users to receive feedback on their mental state through a secure app and shareable dashboard. By unlocking valuable insights into brain health, Cogwear aspires to improve individual well-being and performance.

AAPlasma is developing a cold plasma-based system that is based on previously-successful technology capable of achieving in-between-patient decontamination of PPE items to allow for rapid reuse.

Pression is a developer of a patented, non-invasive smart compression platform known as the Wave, which aims to enhance circulation throughout the body and improve cardiac function. The primary focus of the company is to assist heart failure patients, addressing the issue of excess fluid retention, a leading cause of hospitalizations in the United States. By increasing oxygen delivery to vital organs, the Wave system seeks to enhance exercise tolerance and overall quality of life for individuals with circulatory conditions. The technology is built on established scientific principles and offers improvements over previous systems, emphasizing patient independence and health.

Hava Health, Inc. is a biotechnology company based in the United States that specializes in developing innovative solutions for nicotine addiction. The company manufactures a smoking cessation device that includes a connected vape pen designed to assist individuals in their efforts to quit smoking. This device pairs with a smartphone application called Hale, which serves as a digital support tool for users undergoing nicotine de-addiction. Through its focus on combining technology with therapeutic approaches, Hava Health aims to provide effective support for those seeking to overcome nicotine dependence.

RoundTrip is disrupting the medical transportation industry by providing on-demand medical transportation for hospitals, healthcare organizations, transportation organizations, and health plans.They get the ins and outs of care coordination because they started as paramedics and EMTs before earning MBAs and executive positions at some of the largest healthcare and medical transportation companies in the world. RoundTrip schedules, dispatches, and monitors non-emergency transportation for organizations and their riders in ten states. A few of their major partners include Mount Sinai Health System, Cooper University Health System, MD Anderson Cancer Center at Cooper, Nemours Children’s Hospital, Crozer-Keystone Health System, and GRTC (the government paratransit program) of Richmond and Henrico Counties, VA. It offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT).

Tridiuum, Inc. is a Philadelphia-based digital health company established in 1997 that specializes in software-as-a-service solutions for behavioral health providers, patients, and health systems. The core offering, Tridiuum1, is a cloud-based platform designed to enhance behavioral health outcomes management by monitoring patient symptoms and treatment progress. It integrates digital health assessments with an analytics engine to identify behavioral health issues, assign risk scores, and provide real-time alerts at the point of care. Additionally, the platform supports video-based virtual visits and other features, enabling clinicians to effectively evaluate and manage patients with various conditions. The company is backed by a team of experts in behavioral medicine and digital health technologies, with a strong foundation in clinical research and a history of contributions to peer-reviewed scientific literature.

RoundTrip is disrupting the medical transportation industry by providing on-demand medical transportation for hospitals, healthcare organizations, transportation organizations, and health plans.They get the ins and outs of care coordination because they started as paramedics and EMTs before earning MBAs and executive positions at some of the largest healthcare and medical transportation companies in the world. RoundTrip schedules, dispatches, and monitors non-emergency transportation for organizations and their riders in ten states. A few of their major partners include Mount Sinai Health System, Cooper University Health System, MD Anderson Cancer Center at Cooper, Nemours Children’s Hospital, Crozer-Keystone Health System, and GRTC (the government paratransit program) of Richmond and Henrico Counties, VA. It offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT).

VitalTrax connects patients with clinical trials with its cloud-based clinical trial network. VitalTrax offers Wing, a solution that simplifies clinical trials enrollment. Wing is a clinical trial network that provides innovative ways for people to easily seek optional treatments for themselves or people that they love and play an important role in helping develop new ways to fight diseases.

Keriton LLC is a provider of a pumped breast milk management system specifically designed for neonatal intensive care units (NICUs). Based in Philadelphia, Pennsylvania, the company offers a comprehensive platform that enhances patient safety and streamlines nursing workflows. This system enables healthcare professionals to track milk-bottle inventory, manage feeding orders, and handle first-in-first-out (FIFO) bottle flow, including notifications for expiry dates and misfeed alerts. The platform also facilitates real-time insights into lactating mothers' milk production patterns and includes a media-sharing feature for nurses to communicate with mothers by sharing photos and videos of their babies. With a track record of managing over 1.5 million feeds and preventing nearly 30,000 errors, Keriton's solution aims to improve health outcomes and reduce the cognitive burden on hospital staff. Since its incorporation in 2016, Keriton has been deployed in numerous larger enterprise health systems, demonstrating its effectiveness in enhancing the care provided to infants in NICUs.

Binto LLC, established in 2015 and based in Philadelphia, Pennsylvania, specializes in creating health supplements aimed at supporting women's reproductive health. The company offers a range of products, including fertility and women's health supplements, as well as organic period products such as tampons. Binto designs supplement kits tailored for women of all ages, utilizing natural and effective ingredients that are gluten-free, vegan-friendly, and free from preservatives and fillers. Each supplement is formulated with methylated folate, focusing on preventative care to enhance women's health from menstruation to menopause. Binto also provides access to licensed healthcare professionals, ensuring that women receive safe and effective over-the-counter products at affordable prices.

Shock Analytics is an early stage biomedical device firm focused on the development of smarter technologies for treating acute and chronic illnesses. Their initial focus is on a noninvasive device to estimate Systemic Vascular Resistance (SVR).

SonoSolve is a revolutionary new device that aims to eliminate catheter-associated complications, using non-invasive sound waves to clear obstructions and biofilms within catheters. SonoSolve is the BUZZ in Blockages!

POLARIS HEALTH DIRECTIONS develops and markets behavioral health outcomes assessment and management systems to help deliver better health outcomes at a reduced cost. Polaris systems are designed for use by health care providers, managed care organizations, government agencies and pharmaceutical companies, and focus on addressing the impact mental health conditions have on physical health and an individual’s welfare. These solutions help Polaris's clients identify, monitor and address psychosocial and behavioral health conditions to curb long-term health effects and costs.

Instadiagnostics Inc. develops a point-of-care (POC) diagnostic platform that aims to bring centralized laboratory testing directly to patients at their bedside. This innovative platform enables early diagnosis and treatment monitoring in various settings, including primary care centers, community clinics, and emergency departments. By eliminating the need for additional trips for blood tests and reducing lengthy wait times for results, Instadiagnostics enhances patient care and satisfaction. The company, incorporated in 2015 and based in Philadelphia, Pennsylvania, focuses on streamlining the diagnostic process, ultimately aiming to reduce the number of medical visits and overall healthcare costs.

CyberCrunch specializes in data destruction and e-waste disposal solutions, offering comprehensive recycling services for a wide range of electronic equipment, including computers, monitors, networking devices, and batteries. The company provides secure destruction services such as on-site and off-site shredding, magnetic degaussing, and low-level wiping, ensuring permanent data destruction. Additionally, CyberCrunch offers IT consulting services for businesses undergoing workstation replacements, office relocations, and asset management. The company serves various sectors, including healthcare, financial services, education, and small businesses. Founded in 2010 in Greensburg, Pennsylvania, CyberCrunch was formerly known as Commonwealth Computer Recycling, LLC before rebranding in February 2017.

Ultraflex Systems specializes in designing and engineering custom Range of Motion (ROM) braces that enhance movement and promote active living. With over 25 years of experience, the company collaborates closely with physicians, physical therapists, and specialists to deliver innovative orthopedic and neurological solutions. Ultraflex Systems distinguishes itself through a dedicated direct care team, which includes sales professionals and certified orthotists or fitters. This team oversees the entire process from the physician's referral to brace delivery and subsequent patient follow-up. The company’s custom-molded braces are crafted in its fabrication facilities to ensure optimal fit and effectiveness, ultimately improving joint and limb motion and supporting the musculoskeletal system for better patient outcomes.

Cagent Vascular, LLC is a medical device company based in Wayne, Pennsylvania, focused on developing innovative solutions for cardiovascular diseases. The company specializes in angioplasty balloons that utilize proprietary serration technology to enhance treatment outcomes. Its flagship product, the Serranator, features serrated metal strips embedded in a semi-compliant balloon, designed specifically for the treatment of atherosclerosis and conditions such as peripheral artery disease and chronic limb-threatening ischemia. By employing a minimally invasive approach, Cagent Vascular aims to improve vessel dilatation during cardiovascular interventions, ultimately enhancing patient care and quality of life. Founded in 2014, the company is dedicated to advancing intravascular technology in the medical field.

Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Their development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrition (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.

Instadiagnostics Inc. develops a point-of-care (POC) diagnostic platform that aims to bring centralized laboratory testing directly to patients at their bedside. This innovative platform enables early diagnosis and treatment monitoring in various settings, including primary care centers, community clinics, and emergency departments. By eliminating the need for additional trips for blood tests and reducing lengthy wait times for results, Instadiagnostics enhances patient care and satisfaction. The company, incorporated in 2015 and based in Philadelphia, Pennsylvania, focuses on streamlining the diagnostic process, ultimately aiming to reduce the number of medical visits and overall healthcare costs.

Arcadian Telepsychiatry, LLC is a provider of psychiatric services that connects mental health professionals with patients in both remote and urban locations. The company offers a comprehensive range of services, including on-demand emergency consultations for emergency departments and crisis centers, inpatient consultations, initial psychiatric evaluations, medication management, and scheduled clinics for children, adolescents, and adults. Additionally, Arcadian conducts pre-admission psychiatric assessments, staffing conferences with hospital personnel, and provides training and education on psychiatric emergency services and telepsychiatry. The organization also facilitates a network for video conferencing and Internet access among hospitals, clinics, and public health departments, and delivers behavioral health solutions for skilled nursing and assisted living facilities. Founded in 2012 and headquartered in Fort Washington, Pennsylvania, Arcadian Telepsychiatry aims to enhance access to mental health care while improving collaboration between providers, families, and patients.

Kynectiv, Inc. specializes in simulation-based products and technology platforms that cater to global audiences, particularly in the healthcare sector. The company offers a learning platform that enables organizations to design assessment, education, and training programs, enhancing decision-making through real-world engagement. Notable products include CommSim, which facilitates remote interactions between role-playing coaches and learners, and Synapse DX, a comprehensive solution aimed at helping healthcare organizations understand and influence audience decision-making experiences. Founded in 2010 and headquartered in Chadds Ford, Pennsylvania, Kynectiv was previously known as DecisionSim, Inc. and has operated as a subsidiary of US HealthConnect since 2019.

Grand Round Table (GRT) is an innovative clinical decision support tool integrated into the electronic health record. The technology allows doctors to tap into the collective intelligence of doctors who have come before them to arrive at the correct treatment plan faster on sick, diagnostically challenging patients. GRT helps hospitals and clinics save time and money by directing doctors to appropriate solutions faster, reducing the number of unnecessary tests, ineffective treatments, and consultations that patients currently receive. Together with the changing payment models, GRT stands to help translate available medical knowledge and the organizations' own collective intelligence into shared savings by applying effective, peer-reviewed evidence for some of the costliest patients.

DecNut specializes in developing point-of-care technologies aimed at enhancing clinical decision-making across various healthcare settings. The company's tools integrate evidence-based clinical practice guidelines into the workflow of healthcare providers, facilitating improved resource utilization and patient care outcomes. By offering an application that allows professionals to easily aggregate, update, disseminate, and evaluate tailored clinical decision support, DecNut supports healthcare practitioners in making informed decisions, ultimately leading to more efficient and effective healthcare delivery.

PrescribeWell, Inc. is a Hatfield, Pennsylvania-based company that offers a platform-as-a-service designed to assist healthcare providers in tracking and analyzing behavioral modifications, such as obesity treatment, smoking cessation, and stress management. The platform allows healthcare providers to seamlessly integrate its software solution into existing electronic medical records systems, creating a physician-centric hub that supports wellness regimens for patients while optimizing billing processes for providers. By facilitating effective patient-physician engagement and ongoing communication, PrescribeWell aims to enhance patient outcomes in health management, disease prevention, and lifestyle modifications. The company was incorporated in 2012.

Kynectiv, Inc. specializes in simulation-based products and technology platforms that cater to global audiences, particularly in the healthcare sector. The company offers a learning platform that enables organizations to design assessment, education, and training programs, enhancing decision-making through real-world engagement. Notable products include CommSim, which facilitates remote interactions between role-playing coaches and learners, and Synapse DX, a comprehensive solution aimed at helping healthcare organizations understand and influence audience decision-making experiences. Founded in 2010 and headquartered in Chadds Ford, Pennsylvania, Kynectiv was previously known as DecisionSim, Inc. and has operated as a subsidiary of US HealthConnect since 2019.

Overdose of prescription medicine is now the #1 cause of accidental death in the US. Increasing awareness of this problem is placing doctors and practices under intense scrutiny. Under the guidance of pain management practitioners, with research grants and the support of several states, they developed the PASTRx Software as a Service (SaaS) to help doctors efficiently distinguish patients for whom controlled substances can safely be prescribed, from those who require more complex care or additional safety considerations. PASTRx provides multi-source data integration and synthesis, auditability, and institutional oversight in a robust and user friendly interface to protect patients, physicians and health-care institutions.

Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Their development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrition (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.

Photosonix Medical is a company based in Ambler, Pennsylvania, focused on developing innovative skincare treatments for chronic bacterial infections, particularly in the context of moderate to severe acne. The company has created CLENS™, a device that synergistically combines low-level ultrasound stimulation with blue light energy to effectively target biofilms, which are often responsible for persistent skin issues. By offering a home-use treatment option, Photosonix Medical aims to empower users to manage their acne while preventing permanent skin scarring. The primary audience for its products includes dermatologists and primary care physicians who are involved in prescribing effective acne treatments.

Stabiliz Orthopaedics, LLC, founded in 2009 and based in Exton, Pennsylvania, specializes in the development and distribution of orthopedic devices. The company focuses on creating innovative enhancements to existing orthopedic medical technologies, utilizing FDA-approved methods. Their primary aim is to improve clinical outcomes and simultaneously reduce costs for healthcare systems, addressing the challenges faced by both patients and providers in the orthopedic field.

Advent Therapeutics is a pharmaceutical company based in Lumberville, Pennsylvania, dedicated to developing therapies for micro-orphan applications, specifically targeting serious unmet medical needs in neonatal and pediatric populations. The company focuses on legacy drugs aimed at treating disorders in newborn infants, particularly those in intensive care units. By creating prenatal, neonatal, and pediatric medications, Advent Therapeutics enables healthcare professionals to provide advanced care for vulnerable patients, addressing critical gaps in existing treatment options for this underserved demographic.

Vy Corporation is a software development company based in Wayne, Pennsylvania, that specializes in shape detection and object analysis software for the medical imaging market. The company offers CytoSavvy.com, a cloud-based image analysis and data collection service that enables users to upload and analyze images, particularly useful for identifying clusters of cells in liver and kidney biopsies using its patented CellQuant™ search technology. In addition, Vy Corporation provides VectorSavvy.com, which grants users access to advanced image analysis tools for loading images and viewing results, and it also develops custom projects tailored to specific client needs. The company's mission is to assist pathologists and medical researchers in efficiently identifying and analyzing complex cell structures, enhancing the reliability of data for research and diagnostics.

CRO Analytics, LLC specializes in providing data assessment tools and services tailored for sponsors and contract research organizations. The company has developed Performer, a cloud-based clinical trial performance system that includes a trial assessment platform offering in-trial alerts. This platform enables clinical research executives and management teams to enhance research quality, efficiency, and overall performance while achieving cost savings. By utilizing a proprietary validated process, CRO Analytics collects, analyzes, and reports on quality performance indicators in outsourced clinical research. The platform is designed to deliver insights into clinical research performance by capturing thousands of assessments from biopharma and service provider personnel directly involved in outsourced clinical research. Incorporated in 2011 and based in New Hope, Pennsylvania, CRO Analytics stands out with its ability to provide objective, validated performance data across various metrics, including service provider, sponsor, region, study type, phase, functional area, and therapeutic area.

HealthQX specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its VBP analytics platform, ClarityQx, provides the capabilities to design, implement, and monitor the on-going performance of payment models such as episodic, bundled, or accountable care arrangements. The company was founded in 2012 and is based in King Of Prussia, Pennsylvania.

Grand Round Table (GRT) is an innovative clinical decision support tool integrated into the electronic health record. The technology allows doctors to tap into the collective intelligence of doctors who have come before them to arrive at the correct treatment plan faster on sick, diagnostically challenging patients. GRT helps hospitals and clinics save time and money by directing doctors to appropriate solutions faster, reducing the number of unnecessary tests, ineffective treatments, and consultations that patients currently receive. Together with the changing payment models, GRT stands to help translate available medical knowledge and the organizations' own collective intelligence into shared savings by applying effective, peer-reviewed evidence for some of the costliest patients.

BioDetego is focused on advancing cancer treatment through its innovative biomarker test, VASPfore, which is designed to optimize the selection of chemotherapy protocols. This test assesses the metastatic risk in colorectal cancer patients, allowing healthcare providers to identify high-risk individuals who are likely to benefit from chemotherapy while sparing low-risk patients from unnecessary and potentially harmful treatments. By providing actionable insights, VASPfore aims to improve patient outcomes and enhance the efficiency of cancer management. BioDetego anticipates significant cost savings for payors, estimating reductions of over $150 million annually in treatment expenses. The company is led by David Zuzga, Ph.D., and Giovanni M. Pitari, M.D., Ph.D., both of whom bring extensive expertise in cell and molecular biology and translational oncology, respectively.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.

Stabiliz Orthopaedics, LLC, founded in 2009 and based in Exton, Pennsylvania, specializes in the development and distribution of orthopedic devices. The company focuses on creating innovative enhancements to existing orthopedic medical technologies, utilizing FDA-approved methods. Their primary aim is to improve clinical outcomes and simultaneously reduce costs for healthcare systems, addressing the challenges faced by both patients and providers in the orthopedic field.

EyeIC, Inc. is a medical technology company focused on developing and commercializing imaging technologies for eye care applications. Based in Wayne, Pennsylvania, EyeIC serves eye care professionals and clinics by offering the MatchedFlicker device, which monitors the onset and progression of glaucoma through change detection in time series retinal photographs. The technology aligns and registers images taken at different times, creating a superimposed view that aids in accurate diagnosis. Additionally, EyeIC's software includes an easy-to-use application that streamlines image processing, interpretation, and reporting, facilitating the detection of various retinal conditions such as diabetic retinopathy and retinopathy of prematurity. Established in 2004, EyeIC aims to simplify workflows for clinicians and enhance patient care in the field of ophthalmology.

SkillSurvey Inc. offers cloud-based reference checking and credentialing solutions designed to enhance the hiring process for employers. Founded in 2001 and based in Berwyn, Pennsylvania, the company provides various products, including SkillSurvey Reference, which automates the reference checking process, and Hire 360, an online assessment tool that predicts a candidate's job performance. Additionally, SkillSurvey Credential OnDemand facilitates immediate online responses from applicants and references, while SkillSurvey Source aids in candidate sourcing through referrals. The company's technology is particularly beneficial for sectors such as healthcare, higher education, staffing, and retail, enabling organizations to efficiently verify candidate qualifications and skills. By leveraging data-driven insights, SkillSurvey's patented solutions help clients make informed hiring decisions, ultimately improving business performance and employee retention.

Ceptaris Therapeutics, Inc. is a privately held specialty pharmaceutical company focused on developing a proprietary gel formulation of mechlorethamine hydrochloride for treating early-stage (stages I-IIA) mycosis fungoides, a form of Cutaneous T-Cell Lymphoma (CTCL). If approved, this investigational drug would be the first topical mechlorethamine product available for managing the signs and symptoms of this rare cancer. In addition to this primary focus, Ceptaris is also involved in developing other therapeutic products, including YT-1006, an NMDA antagonist aimed at treating neuropathic pain while minimizing side effects associated with NMDA. The company's innovative approaches enable healthcare professionals to address both dermatological and central nervous system disorders effectively.

SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical company located in Jenkintown, Pennsylvania. The company specializes in creating drugs derived from microbiome-derived metabolites aimed at treating chronic inflammatory diseases and cancer. By harnessing compounds discovered in the human microbiome, SFA Therapeutics seeks to provide innovative therapeutic solutions for various medical conditions, including autoimmune diseases and liver disorders.